Older Adults Show Promising Response to Immunotherapy Despite Immune System Changes with Age
Recent research from Johns Hopkins University highlights that older adults with cancer respond remarkably well to immunotherapy treatments, such as immune checkpoint inhibitors, despite experiencing age-related changes in their immune systems. This study, published in Nature Communications, investigated immune responses in patients aged 65 and older, revealing that these patients benefit just as much, if not more, from immunotherapy compared to younger individuals.
Cancer incidence, particularly solid tumors, is highest among older adults, yet they often face poorer treatment outcomes than younger patients. This discrepancy is partly due to natural immune decline with age, which could theoretically reduce the effectiveness of immune-based therapies. However, the new findings suggest that immune checkpoint inhibitors remain effective across age groups.
The researchers examined immune cells and cytokines—proteins involved in immune signaling—in the blood of approximately 100 patients undergoing immunotherapy. While both older and younger patients experienced similar benefits, notable differences in immune responses were observed. For instance, older patients' T cells, which are crucial for targeting and destroying cancer cells, showed signs of previous exposure or 'experienced' cells, indicating that their immune systems may require additional stimulation to respond effectively.
These insights could help clinicians refine immunotherapy approaches tailored to different age groups, potentially boosting outcomes while minimizing side effects. The team plans to further explore immune cells within tumors to understand how aging influences immune responses at the tumor site. Ultimately, the goal is to develop personalized treatments that account for age-related immune changes, improving overall cancer care for older adults.
The study underscores the importance of not delaying or withholding immunotherapy based solely on age and emphasizes the need to consider immune system dynamics when designing cancer treatments. By understanding how aging affects immune responses, medical professionals can enhance the efficacy and safety of immunotherapies for all patients.
Source: https://medicalxpress.com/news/2025-04-older-adults-immunotherapy-age-immune.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Newly Discovered Brain Cells Play a Key Role in Handling Uncertainty
New research uncovers specialized brain cells in the frontal cortex that are active during uncertain decision-making, offering insights into learning and adaptability in both animals and humans.
Study Links Maternal Asthma to Risks for Newborns
Research from the University of Alberta links maternal asthma to increased risks of preterm birth, low birth weight, and cesarean sections, highlighting the importance of asthma management during pregnancy.
Ethical and Policy Considerations in In Vitro Gametogenesis: A Comprehensive Report
A new comprehensive report examines the ethical, legal, and policy challenges of in vitro gametogenesis, highlighting the need for proactive regulation to safely advance this transformative fertility technology.
New Discoveries in Ovarian Cancer: The Role of Whole-Genome Doubling in Treatment Development
Recent studies reveal that whole-genome doubling plays a key role in ovarian cancer progression and immune suppression, paving the way for innovative treatment strategies. Learn how understanding this process could improve outcomes for patients with high-grade serous ovarian carcinoma.